Amphastar Pharms Action
ActionActionPrix
Questions fréquentes
Quelle est la capitalisation boursière de Amphastar Pharms ?
Quel est le ratio cours/bénéfice (P/E) de Amphastar Pharms ?
Quel est le bénéfice par action (BPA) de Amphastar Pharms ?
Quelles sont les évaluations des analystes et le prix cible de l'action Amphastar Pharms ?
Quel est le chiffre d'affaires de Amphastar Pharms sur les douze derniers mois ?
Quel est l'EBITDA de Amphastar Pharms ?
Quel est le flux de trésorerie disponible de Amphastar Pharms ?
Quel est le bêta à 5 ans de l'action Amphastar Pharms ?
Combien d'employés compte Amphastar Pharms, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Amphastar Pharms ?
Finances
Capitalisation boursière
2,35 Md $USbêta sur 5 ans
0,81BPA (TTM)
3,005 $USFree Float
37,50 MRatio P/E (TTM)
16,16Recettes (TTM)
723,55 M $USEBITDA (TTM)
266,61 M $USCash-flow disponible (TTM)
170,15 M $USCotation
Notes des analystes
L'objectif de prix est de 63,25 $US et l'action est analysée par 6 analystes.
Acheter
4
Hold
2
Vendre
0
Informations
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. Its segments include finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Its pipeline has over 20 product candidates, including generic ANDAs, biosimilar, and others.
1 761
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire